Skip to main content
NCBI home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1986 Feb;39(2):199–203. doi: 10.1136/jcp.39.2.199

Dihydropteridine reductase activity in dried blood spots: effects of aging and senile dementia of the Alzheimer type.

C M Jeeps, A Silcox, B Lloyd, B E Clayton
PMCID: PMC499677  PMID: 3950042

Abstract

Dihydropteridine reductase (EC 1.6.99.7) (DHPR) activity was measured in blood spots from 50 neonates, 52 healthy adults aged 30-62 years, and 21 elderly controls aged 67-97 years, as well as 32 demented patients of whom 25 had senile dementia of the Alzheimer type. Enzyme activity was stable for seven days at 4 degrees C and for at least 14 days at -20 degrees C. No important difference was found between the DHPR activity of venous and capillary blood. DHPR activity was considerably lower in the healthy adult group compared with neonates and the elderly group, and there was no sex difference at any age. The erythrocyte DHPR activity of patients with senile dementia of the Alzheimer type was similar to that of elderly controls. This result differs from that previously reported for leucocytes.

Full text

PDF
199

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adolfsson R., Gottfries C. G., Roos B. E., Winblad B. Changes in the brain catecholamines in patients with dementia of Alzheimer type. Br J Psychiatry. 1979 Sep;135:216–223. doi: 10.1192/bjp.135.3.216. [DOI] [PubMed] [Google Scholar]
  2. Alfrey A. C., LeGendre G. R., Kaehny W. D. The dialysis encephalopathy syndrome. Possible aluminum intoxication. N Engl J Med. 1976 Jan 22;294(4):184–188. doi: 10.1056/NEJM197601222940402. [DOI] [PubMed] [Google Scholar]
  3. Arai N., Narisawa K., Hayakawa H., Tada K. Hyperphenylalaninemia due to dihydropteridine reductase deficiency: diagnosis by enzyme assays on dried blood spots. Pediatrics. 1982 Sep;70(3):426–430. [PubMed] [Google Scholar]
  4. Aziz A. A., Leeming R. J., Blair J. A. Tetrahydrobiopterin metabolism in senile dementia of Alzheimer type. J Neurol Neurosurg Psychiatry. 1983 May;46(5):410–413. doi: 10.1136/jnnp.46.5.410. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Barford P. A., Blair J. A., Eggar C., Hamon C., Morar C., Whitburn S. B. Tetrahydrobiopterin metabolism in the temporal lobe of patients dying with senile dementia of Alzheimer type. J Neurol Neurosurg Psychiatry. 1984 Jul;47(7):736–738. doi: 10.1136/jnnp.47.7.736. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Besson J. Dementia: biological solution still a long way off. Br Med J (Clin Res Ed) 1983 Oct 1;287(6397):926–927. doi: 10.1136/bmj.287.6397.926. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Blessed G., Tomlinson B. E., Roth M. The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Br J Psychiatry. 1968 Jul;114(512):797–811. doi: 10.1192/bjp.114.512.797. [DOI] [PubMed] [Google Scholar]
  8. Coyle J. T., Price D. L., DeLong M. R. Alzheimer's disease: a disorder of cortical cholinergic innervation. Science. 1983 Mar 11;219(4589):1184–1190. doi: 10.1126/science.6338589. [DOI] [PubMed] [Google Scholar]
  9. Cross A. J., Crow T. J., Perry E. K., Perry R. H., Blessed G., Tomlinson B. E. Reduced dopamine-beta-hydroxylase activity in Alzheimer's disease. Br Med J (Clin Res Ed) 1981 Jan 10;282(6258):93–94. doi: 10.1136/bmj.282.6258.93. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Danks D. M., Bartholomé K., Clayton B. E., Curtius H., Gröbe H., Kaufman S., Leeming R., Pfleiderer W., Rembold H., Rey F. Malignant hyperphenylalaninaemia--current status (June 1977). J Inherit Metab Dis. 1978;1(2):49–53. doi: 10.1007/BF01801843. [DOI] [PubMed] [Google Scholar]
  11. Danks D. M., Cotton R. G., Schlesinger P. Letter: Tetrahydrobiopterin treatment of variant form of phenylketonuria. Lancet. 1975 Nov 22;2(7943):1043–1043. doi: 10.1016/s0140-6736(75)90335-9. [DOI] [PubMed] [Google Scholar]
  12. Davies P., Katzman R., Terry R. D. Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementa. Nature. 1980 Nov 20;288(5788):279–280. doi: 10.1038/288279a0. [DOI] [PubMed] [Google Scholar]
  13. Davies P., Maloney A. J. Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet. 1976 Dec 25;2(8000):1403–1403. doi: 10.1016/s0140-6736(76)91936-x. [DOI] [PubMed] [Google Scholar]
  14. Gottfries C. G., Gottfries I., Roos B. E. The investigation of homovanillic acid in the human brain and its correlation to senile dementia. Br J Psychiatry. 1969 May;115(522):563–574. doi: 10.1192/bjp.115.522.563. [DOI] [PubMed] [Google Scholar]
  15. Gottfries C. G. The metabolism of some neurotransmitters in ageing and dementia disorders. Gerontology. 1982;28 (Suppl 2):11–19. doi: 10.1159/000212587. [DOI] [PubMed] [Google Scholar]
  16. Hachinski V. C., Iliff L. D., Zilhka E., Du Boulay G. H., McAllister V. L., Marshall J., Russell R. W., Symon L. Cerebral blood flow in dementia. Arch Neurol. 1975 Sep;32(9):632–637. doi: 10.1001/archneur.1975.00490510088009. [DOI] [PubMed] [Google Scholar]
  17. Hosoda S., Glick D. Studies in histochemistry. LXXIX. Properties of tryptophan hydroxylase from neoplastic murine mast cells. J Biol Chem. 1966 Jan 10;241(1):192–196. [PubMed] [Google Scholar]
  18. KAUFMAN S. A new cofactor required for the enzymatic conversion of phenylalanine to tyrosine. J Biol Chem. 1958 Feb;230(2):931–939. [PubMed] [Google Scholar]
  19. KAUFMAN S., LEVENBERG B. Further studies on the phenylalanine-hydroxylation cofactor. J Biol Chem. 1959 Oct;234:2683–2688. [PubMed] [Google Scholar]
  20. Kaufman S., Holtzman N. A., Milstien S., Butler L. J., Krumholz A. Phenylketonuria due to a deficiency of dihydropteridine reductase. N Engl J Med. 1975 Oct 16;293(16):785–790. doi: 10.1056/NEJM197510162931601. [DOI] [PubMed] [Google Scholar]
  21. Leeming R. J., Blair J. A., Melikian V. Biopterin derivatives in senile dementia. Lancet. 1979 Jan 27;1(8109):215–215. doi: 10.1016/s0140-6736(79)90614-7. [DOI] [PubMed] [Google Scholar]
  22. Mann D. M., Lincoln J., Yates P. O., Stamp J. E., Toper S. Changes in the monoamine containing neurones of the human CNS in senile dementia. Br J Psychiatry. 1980 Jun;136:533–541. doi: 10.1192/bjp.136.6.533. [DOI] [PubMed] [Google Scholar]
  23. Morar C., Whitburn S. B., Blair J. A., Leeming R. J., Wilcock G. K. Tetrahydrobiopterin metabolism in senile dementia of Alzheimer type. J Neurol Neurosurg Psychiatry. 1983 Jun;46(6):582–582. doi: 10.1136/jnnp.46.6.582. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Narisawa K., Arai N., Ishizawa S., Ogasawara Y., Onuma A., Iinuma K., Tada K. Dihydropteridine reductase deficiency: diagnosis by leukocyte enzyme assay. Clin Chim Acta. 1980 Aug 19;105(3):335–342. doi: 10.1016/0009-8981(80)90113-8. [DOI] [PubMed] [Google Scholar]
  25. Perry E. K., Tomlinson B. E., Blessed G., Bergmann K., Gibson P. H., Perry R. H. Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. Br Med J. 1978 Nov 25;2(6150):1457–1459. doi: 10.1136/bmj.2.6150.1457. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Rossor M. N., Iversen L. L., Reynolds G. P., Mountjoy C. Q., Roth M. Neurochemical characteristics of early and late onset types of Alzheimer's disease. Br Med J (Clin Res Ed) 1984 Mar 31;288(6422):961–964. doi: 10.1136/bmj.288.6422.961. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Schneck M. K., Reisberg B., Ferris S. H. An overview of current concepts of Alzheimer's disease. Am J Psychiatry. 1982 Feb;139(2):165–173. doi: 10.1176/ajp.139.2.165. [DOI] [PubMed] [Google Scholar]
  28. Smith I., Clayton B. E., Wolff O. H. New variant of phenylketonuria with progressive neurological illness unresponsive to phenylalanine restriction. Lancet. 1975 May 17;1(7916):1108–1111. doi: 10.1016/s0140-6736(75)92498-8. [DOI] [PubMed] [Google Scholar]
  29. Tkach J. R., Hokama Y. Autoimmunity in chronic brain syndrome. A preliminary report. Arch Gen Psychiatry. 1970 Jul;23(1):61–64. doi: 10.1001/archpsyc.1970.01750010063011. [DOI] [PubMed] [Google Scholar]
  30. Williams A. C., Levine R. A., Chase T. N., Lovenberg W., Calne D. B. CFS hydroxylase cofactor levels in some neurological diseases. J Neurol Neurosurg Psychiatry. 1980 Aug;43(8):735–738. doi: 10.1136/jnnp.43.8.735. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES